Skip to main content
Toggle navigation
Login
Search
Home
Tweets by SLAS2022
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Attendees who have favorited this...
Emma Åkerlund
Postdoctoral Researcher
Karolinska Institutet
Roya Amini-Naieni
CEO
Trilobio
Arpitha Banaji
Scientist
Millipore Sigma
Benjamin Cappiello
Chief Business Officer
AxoSim, Inc.
Paul Carman
Business Development Manager
Araceli Biosciences
Sara Dunne
Ms
Northwestern University
I heart SLAS
Jason Finley
Biologist
NIST Natl Inst of Standards & Technology
Xiaoran Fu
Head of DNA
Asimov
I heart SLAS
Ryan Gordon
Sr VP Business Development
Stem Pharm, Inc.
Award Judge
Michaela Hatch
Scientist
Recursion Pharmaceuticals
Carl Hung
Customer Engagement
Integrated Surface Technologies
I heart SLAS
Timothy Ikeda
Associate Principal Scientist
AstraZeneca
Sanj Kumar
General Manager
ELRIG
Camille Lawrence
Senior applications specialist
NanoTemper Technologies
William Lloyd
Sr Systems Engineer
Akadeum
Yael Mamane
Director of Biology
Repare Therapeutics
Glen Molotnikov
Strategy Leader Biotherapeutics
PerkinElmer
Tuyen Nguyen
Sensior Scientist
Alnylam Pharmaceuticals
Bhargavi Rajan
Associate Director
Kite Pharma
Allan Reyes
Principal Scientist
Pfizer
Elizabeth Scott
Senior Automation Scientist
Bit.Bio
Glauco Souza
Director of Global Business Development
Greiner Bio-One North America, Inc.
Jenna Stone
Associate Principal Scientist
Astrazeneca
Speaker
Emilia Temple-Wheeler
Scientist
Recursion
Lucas Thal
Scientist
Neurocrine Biosciences
Yuan Tian
Postdoctoral Fellow
Auburn University
Matt Troutman
Director, High Throughput Screening and Analytics
Interius BioTherapeutics
Maggie Vantangoli Policelli
Director of Marketing
Araceli Biosciences
Wong Victor
CSO
Core Life Analytics BV
Poster Presenter, I heart SLAS
Victoria Wagner
MBA Candidate
Johns Hopkins University
Steve Walker
Sr. Scientist
Abbvie
Yufei Wang
Research Fellow
Dana-Farber Cancer Institute
John Woodward
Head of Automation
Nitrase Therapeutics
Peter Worthington
Director of Drug Discovery
Visikol
